Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry


Verheugt F. W. A. , Gao H., Al Mahmeed W., Ambrosio G., Angchaisuksiri P., Atar D., ...Daha Fazla

EUROPEAN HEART JOURNAL, cilt.39, sa.6, ss.464-473, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 39 Konu: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1093/eurheartj/ehx730
  • Dergi Adı: EUROPEAN HEART JOURNAL
  • Sayfa Sayıları: ss.464-473

Özet

Aims Current atrial fibrillation (AF) guidelines discourage antiplatelet (AP) monotherapy as alternative to anticoagulants (ACs). Why AP only is still used is largely unknown.